Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Juneja"


10 mentions found


JPMorgan analyst Vivek Juneja upgraded the regional bank stock to an overweight rating from neutral, simultaneously lifting his price target to $39.50 from $37.50. — Lisa Kailai Han 6:27 a.m.: Deutsche Bank downgrades Starbucks after disappointing quarterly earnings Starbucks could feel some near-term pressure, according to Deutsche Bank. Analyst C. Stephen Tusa also raised his price target to $111 from $110, implying that shares of 3M could rally 15% from here. 3M stock has added nearly 6% so far in 2024, but the stock is still trading at an attractive valuation given the company's characteristics, Tusa said. Amongst the group, JPMorgan analyst Doug Anmuth has the highest price target of $240, which implies that Amazon stock could rally another 37% from here.
Persons: Vivek Juneja, Juneja, — Lisa Kailai Han, Samik Chatterjee, Chatterjee, Lauren Silberman, Silberman, Lisa Kailai Han, Stephen Tusa, Tusa, 3M's, Morgan Stanley, Doug Anmuth, Anmuth, — Lisa Kailai Han — CNBC's Michael Bloom Organizations: CNBC, JPMorgan, Starbucks, Deutsche Bank, Fifth, Bancorp, Logitech, 3M, Barclays, Bank of America, Amazon, Services, Wall Street, Locations: China
Here are JPMorgan's top stock picks heading into April
  + stars: | 2024-04-01 | by ( Lisa Kailai Han | ) www.cnbc.com   time to read: +2 min
JPMorgan added two new names to its list of top stocks as April begins — Bank of America and CarMax . However, his price target of $35 implies that shares could fall 8% from their Thursday close. On the other hand, analyst Rajat Gupta views CarMax as a short idea, with his $60 price target suggesting approximately 31% downside from where the stock closed on Thursday. Here are some of the top picks that made JPMorgan's list: Growth stock Danaher is one returning name to the list. Analyst Tami Zakaria's $385 price target corresponds to a further 5% rally from the stock's Thursday close.
Persons: Vivek Juneja, Juneja, Rajat Gupta, CarMax, Rachel Vatnsdal's, Tami Zakaria's, — CNBC's Michael Bloom Organizations: JPMorgan, — Bank of America, Bank of America, of America, " Bank of America, Caterpillar
BENGALURU, May 9 (Reuters) - Shares of Manforce condom maker Mankind Pharma Ltd (MNKI.NS) surged as much as 31% in debut trading on Tuesday, valuing the company at 566.43 billion rupees ($6.93 billion) in the country's biggest listing so far this year. The company, which also owns India's top at-home pregnancy testing kit Prega News, opened at 1,300 rupees, staying above that mark through the morning session and hitting its highest at 1,414 rupees. It was seeking a valuation of 432.64 billion rupees ($5.29 billion) at the upper end of a price band it set for its initial public offering last month. The strong debut will likely lift the sentiment for the IPO market overall." The company's IPO had an offer for sale of shares worth 43.26 billion rupees from existing shareholders, including its founder Ramesh Juneja, and allocated 12.98 billion rupees worth of shares to 77 anchor investors including Canada Pension Plan Investment Board, Government of Singapore, Goldman Sachs and Abu Dhabi Investment Authority.
JPMorgan refreshed its list of top stock picks heading into April, including a bank stock that's had a rocky start to the year. To kick off the month of April, JPMorgan added two new names to its focus list: VICI Properties and Regions Financial. The other new name on the list, Regions Financial , has declined 15% in 2023. GM shares are up 6.2% in 2023. JPMorgan removed two names from its list: Intellia Therapeutics and Jones Lang LaSalle .
The move by major banks on Thursday to extend a much needed lifeline to First Republic should help reignite confidence in the sector after a difficult week, Wall Street says. "We view the move by the industry as a positive step to stem contagion amid the regional bank crisis," wrote Evercore ISI's John Pancari in a Thursday note. "We believe the move sends a message of broader stability for the sector and should help further temper depositor fears," and enables the "bank to fight another day." First Republic shares have plummeted 58% this week, after the failure of Silicon Valley Bank triggered a massive selloff among regional bank stocks and panic deposit flight from customers. "It is also a sly vote of confidence in the contributing banks," he said.
The capital issues at SVB Financial sparked a sell-off among bank stocks on Thursday, but the tech-focused bank's woes will likely not be a preview of wider issues in the banking system, according to Wall Street analysts. KBWB 5D mountain Bank stocks fell sharply on Thursday. Morgan Stanley analysts Manan Gosalia and Betsy Graseck echoed that sentiment, saying in a note that the issues at hand appeared to specific to SVB. "Current pressures facing SIVB are highly idiosyncratic and should not be viewed as a read-across to other banks we cover. RBC analyst Gerard Cassidy said that banks without large retail customer bases could be in for a rocky period.
It's been a confusing time for investors in bank stocks. Analysts are expecting a mixed bag of conflicting trends when four of the largest U.S. banks report fourth-quarter results Friday. "Our continued cautious view ... reflects ongoing macro risks and likely weakening bank fundamentals —including peaking net interest margins," Deutsche Bank analyst Matt O'Connor said in Jan. 5 note. The outlook Investors tend to discount fourth-quarter results in favor of what managements say about their outlooks for the coming year. "We expect above-consensus expense guides will likely weigh on bank stocks during 4Q22 earnings as managements communicate their 2023 budget plans," Graseck said.
SoftBank's Vision Fund just experienced one of its most dismal years in its history. SoftBank's Vision Fund was once a power broker, having raised a jaw-dropping $100 billion in 2017, followed by plans to raise $108 billion for Vision Fund 2 in 2019 — two of the largest venture-investing vehicles ever established. But insiders are now questioning if it will ever regain influence, according to 11 ex-Vision Fund investors, former employees, VCs, and industry analysts who weighed in on the future of the Vision Fund. One ex-Vision Fund investor described Son, now taking the reins of Vision Fund 2, as someone who is "not a manager." Given its investing performance so far, the obvious question is what happens once Vision Fund 2 has reached full investment.
While the S&P 500 is down nearly 20% year-to-date, its energy sector is up about 60% so far in 2022. JPMorgan recommends these 8 Russell 2000-listed energy stocks amid a harsh macro backdrop. Amid the central bank's monetary tightening to combat near 40-year high inflation, stocks continue their downtrend. Energy stocks, in particular, could be a nice buying opportunity as the US economy appears to be heading toward a recession. With a mix of both growth and value stocks, JPMorgan recommends these 10 Russell 2000-listed stocks amid harsh macro conditions.
The firm's Analyst Focus List is a compilation of its analysts' favorite names for various investment strategies, and it gets a refresh every month. Almost all the stocks included have overweight ratings and are recommended for growth or value strategies. For November, the analysts removed a handful of stocks, including First Republic , and added just one: the cancer treatment developer BioAtla . JPMorgan included the stock for a near-term strategy and put a $23 price target on it. McDonald's , Allstate , AbbVie and Qualcomm are among the value stocks that are in the mix.
Total: 10